Clinical Trial Update: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

View source ↗

Summary

Observational study evaluating safety and efficacy of Remsima in rheumatoid arthritis; the study was terminated but results were posted on February 5, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Remsima (infliximab)

Snippet

Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Status: TERMINATED | Results posted: 2024-02-05